研究者
J-GLOBAL ID：201801013847092176   更新日: 2024年07月17日

大浪 俊平

Shumpei Ohnami
研究分野 (1件)： 腫瘍生物学
競争的資金等の研究課題 (2件)：
  • 2018 - 2021 KRAS変異に制御される遺伝子の機能解析と革新的治療薬の開発
  • 2011 - 2013 生活習慣・環境因子との相互作用に関与する遺伝子多型と膵癌リスク
論文 (48件)：
  • Keiichi Ohshima, Takeshi Nagashima, Keiichi Fujiya, Keiichi Hatakeyama, Yuko Watanabe, Kimiko Morimoto, Fukumi Kamada, Yuji Shimoda, Sumiko Ohnami, Akane Naruoka, et al. Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations. Cancer research communications. 2023. 3. 4. 684-696
  • Takeshi Nagashima, Kenichi Urakami, Yuji Shimoda, Keiichi Ohshima, Masakuni Serizawa, Keiichi Hatakeyama, Sumiko Ohnami, Shumpei Ohnami, Akane Naruoka, Yasue Horiuchi, et al. Comparative analysis of tumor content estimation methods based on simu- lated tumor samples identified their impact on somatic variant detection in cancer whole genome sequencing. Biomedical research (Tokyo, Japan). 2023. 44. 4. 161-171
  • Keiichi Hatakeyama, Takeshi Nagashima, Keiichi Ohshima, Sumiko Ohnami, Shumpei Ohnami, Yuji Shimoda, Akane Naruoka, Koji Maruyama, Akira Iizuka, Tadashi Ashizawa, et al. Impact of somatic mutations and transcriptomic alterations on cancer aneuploidy. Biomedical research (Tokyo, Japan). 2023. 44. 5. 187-197
  • Sumiko Ohnami, Akane Naruoka, Mitsuhiro Isaka, Maki Mizuguchi, Sou Nakatani, Fukumi Kamada, Yuji Shimoda, Ai Sakai, Keiichi Ohshima, Keiichi Hatakeyama, et al. Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes. Scientific reports. 2022. 12. 1. 17928-17928
  • Yuji Shimoda, Takeshi Nagashima, Kenichi Urakami, Fukumi Kamada, Sou Nakatani, Maki Mizuguchi, Masakuni Serizawa, Keiichi Hatakeyama, Keiichi Ohshima, Tohru Mochizuki, et al. Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients. Biomedical research (Tokyo, Japan). 2022. 43. 4. 115-126
もっと見る
MISC (4件)：
  • Yuki Yamamoto, Naoko Goto, Shumpei Ohnami, Masatoshi Tagawa, Kazunori Aoki. A Cancer-Targeting Ligand Strongly Enhances Oncolytic Activity of a Conditionally Replicative Adenovirus. MOLECULAR THERAPY. 2013. 21. S245-S245
  • Kazunori Aoki, Takeshi Nishimoto, Kimiko Yoshida, Shumpei Ohnami, Kaoru Kurisu, Teruhiko Yoshida. ONCOLYTIC VIRUS THERAPY FOR PANCREATIC CANCER USING AN ADENOVIRUS LIBRARY DISPLAYING RANDOM PEPTIDES ON THE FIBER KNOB. JOURNAL OF GENE MEDICINE. 2010. 12. 12. 1030-1031
  • Kazunori Aoki, Kimiko Yoshida, Yoshiaki Miura, Kazuteru Hatanaka, Takeshi Nishimoto, Shumpei Ohnami, Teruhiko Yoshida. Direct selection of targeted vector from a random peptide library displayed on adenoviral fiber knob. JOURNAL OF GENE MEDICINE. 2006. 8. 12. 1467-1467
  • Kazunori Aoki, Yoshiaki Miura, Kimiko Yoshida, Kazuteru Hatanaka, Takeshi Nishimoto, Shumpei Ohnami, Joanne T. Douglas, David T. Curiel, Teruhiko Yoshida. Direct Selection of Targeted Vector from a Random Peptide Library Displayed on Adenoviral Fiber Knob. MOLECULAR THERAPY. 2006. 13. S7-S7
経歴 (2件)：
  • 2014/04 - 現在 静岡県立静岡がんセンター 研究所 診断技術開発研究部 主任研究員
  • 1995/05 - 2013/03 国立研究開発法人国立がん研究センター 研究所・実験支援施設 施設長
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM